MYD88 and lymphoproliferative syndrome: Another point to consider is MYD88 mutation, and lymphocytic flow‐cytometric markers can become positive in other lymphoproliferative disorders, like marginal zone lymphoma (MZL) or chronic lymphocytic leukemia (CLL).8, 9